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Dioxins and related compounds are
widespread toxic contaminants that persist
in the environment and accumulate in the
food chain. The most potent dioxin,
2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD), produces a wide range of toxic
effects, many of which involve disruption of
endocrine functions (1–4). It is generally
accepted that the diverse toxic effects of
TCDD are mediated by the arylhydrocarbon
receptor (AhR) (5,6), a basic helix-loop-helix
transcription factor with a Per-ARNT-Sim
homology domain (7–9). Ligand-bound
AhR forms a heterodimer with AhR nuclear
transporter (ARNT) or ARNT2, then binds
to the xenobiotic response element (XRE;
also called dioxin response element, DRE)
and alters transcription of target genes
(10,11). In addition to these genomic
effects, there is evidence that TCDD bind-
ing to the AhR also alters signal transduction
by activating protein kinases (12). Thus, the
mechanisms of TCDD toxicity are complex
and probably involve AhR-mediated disrup-
tion of multiple cellular signaling processes.
TCDD disrupts a variety of physiological
functions; however, the finding that expo-
sure to low doses of TCDD during develop-
ment permanently alters reproductive
functions is of particular concern. In male
Holtzman rats, perinatal exposure to TCDD
partially demasculinizes sexual behaviors
(13,14) and interferes with defeminization
of both sexual behaviors (15) and
gonadotropin release patterns (13). Prenatal
exposure to TCDD also demasculinizes sex-
ual behaviors and delays the onset of puberty
in male Long Evans rats but does not appear
to block defeminization of behaviors in this
rat strain (16). In female rats, a single prena-
tal exposure to TCDD delays the onset of
puberty, prolongs the time required to
achieve pregnancy in continuous breeding
situations, and increases the incidence of
constant estrus before old age (16–18). How
developmental exposure to TCDD produces
the observed effects on reproductive func-
tions in adulthood is not clear. However,
both gonadotropin release patterns and sex-
ual behavioral potentials of adults are estab-
lished during the critical period of perinatal
life when the neural substrates controlling
these functions undergo sexual differentia-
tion (19,20). Sexual dimorphism of the
brain is established by exposure of male
brains to testosterone produced by the devel-
oping testes (21–24) and aromatized to
estradiol (E2), the hormone that defeminizes
and masculinizes neural functions (25).
Interestingly, the behavioral deficits and
altered gonadotropin release observed in
males exposed to TCDD are reminiscent of
the effects caused by administration of
antiaromatase or antiestrogenic drugs
(25–27). Considering that TCDD appears
to be antiestrogenic in some tissues (4), it is
possible that it also interferes with estrogen
action in the brain, thereby disrupting sexual
differentiation of brain regions important for
reproduction.
Support for the idea that TCDD may
exert antiestrogenic actions in neural tissue
comes from our previous work showing that
AhR, ARNT, and ARNT2 mRNAs are
found in several brain regions that contain
estrogen receptors (28). Most notably, we
found members of the AhR pathway in the
preoptic area (POA) of the brain, a region
that contains sexually dimorphic nuclei
(29,30). Importantly, neurotransmitter sys-
tems in the POA show sex differences in
adulthood as a result of perinatal steroid hor-
mone manipulations (31,32). Furthermore,
speciﬁc subdivisions of the POA are required
for estrogen-dependent luteinizing hormone
(LH) surge release (33,34) and for the expres-
sion of male sexual behaviors (35,36).
Therefore, it seems likely that developmental
exposure to TCDD may permanently demas-
culinize and feminize the male brain by
interfering with estrogen action in the POA.
The neural targets that mediate the
organizational effects of steroids and might
also be targets of TCDD have not been
clearly delineated. However, γ-aminobutyric
acid (GABA)-ergic neurons throughout the
adult rat brain, including regions of the
POA that control reproduction, express the
AhR gene (37). In addition, the promoter
regions of both glutamic acid decarboxylase
(GAD) 67 and GAD 65 genes contain multi-
ple canonical XRE sequences (38,39). Other
lines of evidence suggest that GABAergic
neurons may also be targets of estrogen and
play a role in differentiation of the POA.
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Developmental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) interferes with
masculinization and defeminization of male sexual behaviors and gonadotropin release patterns.
We previously demonstrated that the mRNA encoding the arylhydrocarbon receptor (AhR), a pro-
tein that mediates TCDD effects, is found in brain regions that control reproductive functions,
most notably in the preoptic area (POA). The pattern of distribution of the AhR gene closely over-
laps that of an enzyme necessary for γ-aminobutyric acid (GABA) synthesis, glutamic acid decar-
boxylase (GAD) 67. To test the hypothesis that GABAergic neurons in the POA are targets of
TCDD during development, we used dual-label in situ hybridization histochemistry (ISHH) to co-
localize GAD and AhR mRNAs in the region. In addition, we used ISHH to determine the effects
of TCDD (1 µg/kg body weight, gestational day 15) on GAD 67 gene expression in POA regions
in pups examined on postnatal day 3. We found that virtually all GABAergic neurons in the POA
expressed the AhR gene. Furthermore, GAD 67 mRNA levels were higher in females than in males
in the rostral POA/anteroventral periventricular nucleus (rPOA/AVPV) and in the rostral portion
of the medial preoptic nucleus (MPN). TCDD abolished sex differences in the rPOA/AVPV but
had no effect in the rostral MPN. In the caudal MPN, there were no sex differences in GAD 67
gene expression, but TCDD depressed expression speciﬁcally in males. Our ﬁndings demonstrate
that GABAergic neurons in the brain are targets of TCDD and may mediate developmental effects
of this contaminant on reproductive function. Key words: androgen, anteroventral, estradiol, GAD,
glutamic acid decarboxylase, hypothalamus, periventricular, preoptic, sexual dimorphism, TCDD.
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(40) and express estrogen receptor (ER)-α
and ER-β mRNA (41). Furthermore, GABA
affects neurogenesis, neural migration, and
apoptosis (42), processes that are all influ-
enced by steroids and involved in creating
sexually dimorphic components of the POA
(43). Taken together, this evidence supports
the hypothesis that TCDD interferes with
sexual differentiation of the brain by inter-
fering with estrogen action in GABAergic
neurons.
To test this hypothesis, we ﬁrst examined
the effects of TCDD on GAD 67 gene
expression in POA regions of male and
female offspring of Holtzman rat dams. We
treated dams with 1 µg TCDD/kg body
weight on gestational day 15 (GD 15) to
replicate conditions previously used to show
that TCDD disrupts masculinization and
defeminization of sexual behaviors and
gonadotropin release patterns (13). We
measured GAD 67 mRNA levels as an index
of GABAergic activity because in adult rats
changes in GAD 67, but not in GAD 65,
gene expression are closely linked to changes
in GABA release into the POA (44). In the
present studies, we used in situ hybridization
histochemistry (ISHH) so that we could
focus on three subdivisions of the POA that
lie in close proximity: a) the rostral POA
containing the anteroventral periventricular
nucleus (rPOA/AVPV), b) the region con-
taining the rostralmost portion of the medial
POA (mPOA), and c) the region containing
the caudalmost mPOA. The AVPV region is
critical for the induction of LH surge release
by E2 (33,34), and the caudal mPOA is a
site at which androgen regulates display of
male sexual behaviors (35,36,45).
We next used dual-label ISHH to verify
that mRNAs encoding the AhR are present
in GABAergic neurons of the POA of devel-
oping brains as they are in adults. We
focused on the AhR gene because it mediates
antiestrogenic effects of TCDD (4,5) and
because our previous work demonstrates that
ARNT and/or ARNT2 genes are expressed in
all POA regions that express the AhR gene
(28). To verify that TCDD effects are not
mediated by decreases in testosterone pro-
duction or interference with aromatase activ-
ity, we used ISHH to measure sex
differences in progestin receptor (PR)
mRNA levels in the mPOA. This approach
took advantage of previous findings that
males have significantly higher levels of PR
than females, because E2 derived from
aromatization of testosterone induces PR
expression (46,47). Finally, to conﬁrm that
all pups used in the study received similar
exposures to TCDD, we used ISHH to
measure CYP1B1 mRNA levels in their liv-
ers. We used CYP1B1 as a marker of expo-
sure because it is a target gene of the AhR
(48). Although TCDD induction of
CYP1A1 gene expression is more robust than
that of CYP1B1, results of preliminary stud-
ies showed that levels of CYP1B1 gene
expression in the liver of TCDD-exposed
dams are more variable than those of
CYP1A1 and also more clearly correlated
with pup survival rates (49). Thus, they
appear to be a more sensitive measure of
individual responsiveness to TCDD.
Materials and Methods
Animals and Tissue Preparation
All the animals in this study were maintained
in accordance with the National Institutes of
Health Guidelines for the Care and Use of
Laboratory Animals (50), and the Institutional
Animal Care and Use Committee of the
University of Massachusetts approved all
treatment protocols used.
For this study, 14 pregnant Holtzman
Sprague-Dawley rats (Harlan Sprague-
Dawley, Madison, WI, USA) were delivered
to the Animal Care Facility at the University
of Massachusetts on day 3 of gestation
(GD 3). The rats were individually housed
and maintained in a temperature- and light-
controlled room (14:10 light:dark cycle;
lights on at 0500 hr) with food and water
available ad libitum.
Each animal was given a Keebler Golden
Vanilla Wafer (Keebler Co., Elmhurst, IL,
USA) and weighed daily from GD 10
through GD 14. By GD 14, rats readily con-
sumed the cookies, usually within 5 min after
they were presented. On GD 15, rats were
weighed and randomly divided into two
groups. One group (n = 7) received vanilla
wafers containing TCDD (1 µg/kg;
AccuStandard, Inc., New Haven, CT, USA),
and the control group (n = 7) received wafers
treated with dimethylsulfoxide (DMSO)
vehicle (Sigma-Aldrich, St. Louis, MO,
USA). Wafers were prepared by applying 75
µL TCDD or DMSO solution and allowing
them to dry 24 hr before distribution to the
rats. Each rat was closely monitored to ensure
that it consumed the entire treated cookie.
Dams were weighed on GD 16, 18, 19, and
20. On GD 20, it was determined that one
TCDD-treated animal and two controls were
no longer pregnant. In addition, one TCDD-
treated dam and pups died during parturition
and pups of another TCDD-treated rat did
not survive longer than 24 hr. Pups from sur-
viving litters were weighed on postnatal day 3
(PND 3; day of birth designated PND 0) and
those used in this study were sacrificed by
decapitation. Both heads and trunks were col-
lected, rapidly frozen on powdered dry ice,
wrapped in Parafilm, and stored in sealed
containers at –80°C until cryosectioned
(Leica CM3000, Nussloch, Germany).
Brains of one male pup and one female
pup from each litter (five TCDD-treated
and seven vehicle-treated litters) were
cryosectioned at 14 µm through the entire
POA, from the region containing the
organum vasculosum of the lamina termi-
nalis through the region containing the
medial POA. No available brain atlas details
the POA region of neonatal rats; therefore,
we used an atlas of the adult brain (51) that
shows the features we observed in tissues of
PND-3 animals. The region we refer to as
the rPOA/AVPV region in PND-3 animals
corresponds to plates 17 and 18 of this atlas.
The rostral MPN region in our studies cor-
responds to plate 19, and the region we
termed caudal MPN includes features
shown in plates 20 and 21. Cryosections 14
µm thick from the trunk region containing
the liver were also obtained from each of
these pups. For both brain and liver,
cryosections were collected and thaw-
mounted onto gelatin-coated slides (two
sections/slide), allowed to dry on a warming
tray at 42°C, then stored at –80°C until
ISHH was performed.
Single-Label ISHH
For these studies, brain sections from the
POA of each of the animals in the study
were hybridized to 33P-labeled cRNA probes
speciﬁc for mRNAs encoding PR or to 35S-
labeled cRNA probes for GAD 65 or GAD
67 mRNAs. In addition, sections containing
liver were hybridized to 33P-labeled cRNA
probes for CYP1B1 mRNA.
Transcription templates. The cDNA
template for probes to PR mRNA was a
550-bp BamHI-SalI cDNA fragment corre-
sponding to bases 383–933 of the full-length
clone kindly provided by O.K. Park-Sarge,
University of Kentucky (Lexington, KY,
USA) (52). For antisense cRNA transcripts,
the plasmid was linearized with BamHI, and
for control sense strand transcripts, the plas-
mid was linearized with SalI.
The template used to prepare radio-
labeled cRNA probe specific for GAD 65
was an 824-bp XbaI-HindIII cDNA frag-
ment corresponding to bases 944–1769 that
we subcloned from the full-length clone (38)
generously provided by A. Tobin, UCLA
(Los Angeles, CA, USA). For antisense
cRNA transcripts, the plasmid was linearized
with XbaI, while HindIII was used in the
preparation of templates for control sense
strand transcripts.
To prepare radiolabeled cRNA probe
specific for GAD 67, we used a 535-bp
HindIII-SacI cDNA fragment correspond-
ing to bases 232–769 that we subcloned
from the full-length clone (38) provided by
A. Tobin. For antisense cRNA transcripts,
the plasmid was linearized with HindIII, and
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for control sense strand transcripts, the
plasmid was linearized with SacI.
The cDNA transcription template for
CYP1B1 mRNA was a 604-bp BamHI-
EcoRV cDNA fragment corresponding to
bases 85–689 of the rat CYP1B1 cDNA pre-
pared using reverse transcription–polymerase
chain reaction (RT-PCR). The forward
primer was 5′CATCTCAACCGCAACTC-
CAA3′ and the reverse primer was 5′AGC-
CTGATGGATGGCACTCT3′. PCR was
performed by first mixing buffer (Life
Technologies, Gaithersburg, MD, USA)
with 200 pM forward and reverse primers,
200 µM dNTPs, and 1.5 mM MgCl2 in a
final volume of 200 µL. The mixture was
heated to 94°C for 3 min in a thermal cycler
before the addition of 10 U Taq polymerase.
Subsequent temperature cycles were 35
cycles at 94°C for 1 min, 57°C for 1 min,
72°C for 1 min, and a final incubation at
72°C for 10 min. The PCR-generated
cDNA fragments were cloned into pCRII-
TOPO (Invitrogen, Carlsbad, CA, USA)
and the identity was conﬁrmed by sequenc-
ing. The plasmid was linearized with BamHI
for transcription of antisense probes and
with EcoRV for sense strand probes.
In vitro transcription. All cRNA probes
were prepared using in vitro transcription
methods described previously (53,54), with
minor modifications. Briefly, for transcrip-
tion of probes for PR, GAD 65, and GAD
67 mRNAs, 90 pmol (9 µM ﬁnal concentra-
tion) of 33P-UTP (New England Nuclear,
Boston, MA, USA) were dried down in a
DNA Speed Vac (Savant, Farmingdale, NY,
USA) and 1.0 µg linearized template, 1×
transcription buffer, 10 mM dithiothreitol
(DTT), 20 U RNAsin (Promega, Madison,
WI, USA), 0.5 mM ATP, CTP, and GTP, 3
µM UTP, and 10 U of RNA polymerase
were added in a total volume of 10 µL. For
transcription of CYP1B1 cRNA probes, 120
pmol (12 µM final concentration) of 33P-
UTP was used and no unlabeled UTP was
added to the transcription mixture. For each
reaction, the mixture was incubated for 30
min at 37°C. A second aliquot of RNA poly-
merase (10 U) was added, and the mixture
was incubated again for 30 min at 37°C.
The template was degraded with 2 U
DNAse in the presence of 20 U RNAsin, 5
µM Tris HCl, 1 µM MgCl2, and 0.5 µL
tRNA (25 µg/µL). The radiolabeled cRNA
probes were extracted with phenol/chloro-
form, then precipitated twice with NaCl and
EtOH and resuspended in 100 µL of 1 mM
EDTA and 10 mM Tris. 
Hybridization procedures. Separate
hybridization runs were conducted for each
of the probes used. In studies of PR, GAD
65, and GAD 67 mRNAs, every fourth slide
(~24 sections) from the POA of each pup
was included. Similarly, every fourth section
containing liver tissue was included for each
pup in a single hybridization run, using the
CYP1B1 cRNA probe. In each run, every
12th section was hybridized to sense strand
probes to verify speciﬁcity of the probe.
After warming for 10 min at room
temperature, sections were processed as
described previously (55). They were first
ﬁxed with 4% formalin–phosphate-buffered
saline for 15 min, then treated with 0.25%
acetic anhydride in 0.1 M triethanolamine,
0.9% NaCl (pH 8.0), dehydrated and delip-
idated in a series of ethanol and chloroform
rinses, and rehydrated to 95% ethanol. After
the sections were dried, the cRNA probes
(~1 × 106 cpm) were applied to each tissue
section in 25 µL of hybridization buffer. The
hybridization buffer contained 2× standard
saline citrate solution (2× SSC; 1× SSC =
0.15 M NaCl and 0.015 M sodium citrate,
pH 7.2), 50% (v/v) formamide, 10% (w/v)
dextran sulfate, 250 µg/mL tRNA, 500
µg/mL sheared single-stranded salmon
sperm DNA, 1× Denhardt’s solution
(0.02% Ficoll, 0.02% polyvinylpyrrolidone,
and 0.02% bovine serum albumin), and 200
mM freshly prepared DTT. Sections were
covered with glass coverslips and incubated
in humid chambers overnight at 55°C.
After hybridization, coverslips were
gently removed and sections washed in two
changes of 1× SSC for 10 min each on an
orbital shaker at room temperature. The
slides were then washed twice with 50%
(v/v) formamide/2× SSC for 20 min at 52°C
and rinsed twice in 2× SSC for 10 min each
rinse. The slides were then incubated in
RNAse buffer with 100 µg/mL of RNAse A
(Roche Corporation, Indianapolis, IN,
USA) at 37°C for 30 min, rinsed twice in 2×
SSC for 10 min each, and then incubated in
50% formamide/2× SSC (v/v) for 20 min at
52°C. Finally, slides were rinsed quickly in
distilled water, then in three separate washes
of 70, 80, and 95% ethanol for 1 min each.
Dried slides were apposed to Kodak BIO-
MAX X-ray film (Eastman Kodak,
Rochester, NY, USA) and exposed for vary-
ing times, determined from preliminary
studies using a small number of test slides.
Sets of identical 14C standards were exposed
to X-ray ﬁlms in each cassette with tissue sec-
tions and were used to verify that the films
did not differ. The exposure times were 72 hr
for sections hybridized to CYP1B1 or PR
probes, 24 hr for GAD 65 probes, and 48 hr
for GAD 67 probes. Films were developed
using a Konica SRX-101A film processor
(Konica Corporation, Tokyo, Japan).
Dual-Label ISHH
For dual-label ISHH studies co-localizing
AhR and GAD mRNAs in cells of the POA,
we used a mixture of two 33P-labeled cRNA
probes for AhR and digoxigenin-labeled
probes for GAD 65 and GAD 67 mRNAs.
Sections from the POAs of three vehicle-
treated pups were used for this study.
Transcription templates. The templates
for preparation of radiolabeled cRNA probes
for AhR mRNA were a 1.2-kb SpeI-BamHI
and a 517-bp fragment of the rat AhR cDNA
that we subcloned from the full-length AhR
cDNA kindly provided by C. Bradfield,
University of Wisconsin (Madison, WI,
USA) (56) into pBluescript II KS+. For anti-
sense transcripts, the plasmid containing the
1.2-kb fragment was linearized with SpeI and
the plasmid containing the 517-bp fragment
was linearized with BamHI.
We used three separate templates to
prepare digoxigenin-labeled cRNA probes
specific for GAD mRNA. GAD 65 and
GAD 67 isoforms are found primarily in
the same cells, and combining the cRNA
probes yields a more easily detectable signal
than one probe alone. Full-length clones
described above were subcloned to prepare
several different constructs. The first was a
628-bp fragment corresponding to bases
315–944 of the full-length GAD 65 clone.
Plasmid was linearized with XbaI for anti-
sense transcripts. The second was a 535-bp
fragment corresponding to bases 232–767
of the full-length GAD 67 clone. This plas-
mid was linearized with HindII for anti-
sense transcripts. The third was an 824-bp
fragment corresponding to bases 944–1769
of the full-length GAD 65 clone. This plas-
mid was linearized with XbaI for antisense
transcripts.
In vitro transcription of digoxigenin-
labeled cRNA probes. 33P-Labeled probes for
AhR were prepared as described above for
preparation of CYP1B1 cRNA probes, using
120 pmol 33P-UTP with no unlabeled UTP
in the reaction. Digoxigenin-UTP–labeled
cRNA probes were transcribed using 1 µg lin-
earized cDNA template, 20 U T3 polymerase
(Promega), transcription buffer, 250 µM
ATP, 250 µM CTP, 250 µM GTP, 50 µM
UTP, 250 µM digoxigenin-UTP (Roche
Corp.), 10 µM DTT, and 1 U RNAsin. This
mixture was incubated for 1 hr, then an addi-
tional aliquot of 20 U T3 polymerase was
added and the mixture incubated for 1 hr at
37°C. The reaction was brought to 100 µL
with nuclease-free water, and the DNA tem-
plate was digested with DNAse I (2 U), in the
presence of 1 U RNAsin. The probe was pre-
cipitated twice with NaCl and EtOH and
resuspended in a solution of 50 µL of 1 mM
EDTA and 10 µM Tris.
Dual-Label ISHH Procedure
Dual-label  in situ hybridization was
performed as described previously (54,57). A
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mixture of radiolabeled probes (1.5 × 106
cpm for each probe) and digoxigenin-labeled
probes (~20 ng of each GAD probe) were
applied to each tissue section in 25 µL of
hybridization buffer containing 50%
formamide, 10% dextran sulfate, 1×
Denhardt’s solution, 2× SSC, 500 mg/mL
heparin sodium salt, and 0.5 mg/mL tRNA.
Sections were hybridized under glass cover-
slips overnight at 55°C. After hybridization,
slides were cooled and coverslips removed in
1× SSC at room temperature, then in two
20-min 2× SSC/50% formamide washes at
52°C, followed by two 1-min rinses in 2×
SSC. The sections were then incubated in
RNAse solution (0.5 M NaCl; 10 mM Tris,
pH 8.0; 1.0 mM EDTA, pH 8.0; containing
100 mg/mL RNAse A) for 30 min at 37°C,
followed by two washes in 2× SSC for 10
min each at room temperature. Next, sec-
tions were incubated in a 20-min wash of 2×
SSC/50% formamide at 52°C, followed by a
brief rinse in 2× SSC.
To prevent nonspecific antibody
binding, we blocked tissue sections for 1 hr
in 5% blocking reagent (Roche Corp.) at
room temperature. After blocking, slides
were washed twice in maleate buffer (0.15 M
NaCl; 0.1 M maleic acid, pH 7.5) for 3 min
each wash. Sections were then incubated in
antidigoxigenin conjugated to horseradish
peroxidase (Roche Corp.; 1:200 in 2% block-
ing reagent) for 48 hr at 4°C, washed 3 times
in maleate buffer for 5 min, then 3 times in
TNT buffer (0.15 M Tris HCl, 0.15 M
NaCl, 0.05% Triton-X) for 5 min each.
Digoxigenin signal was amplified using the
NEN Renaissance Kit (New England
Nuclear, Boston, MA, USA) and visualized
using the ABC Elite Kit (Vector Laboratories,
Burlingame, CA, USA) and freshly prepared
3,3′-diaminobenzidine tetrahydrochloride
solution (DAB; Sigma Chemicals, St.
Louis, MO, USA). DAB solution was pre-
pared by mixing 10 mg DAB in 50 mL 0.1
M Tris (pH 7.6), filtering the solution
through Whatman #1 paper (Whatman
International Ltd., Maidstone, England),
and adding 8 mL of 30% hydrogen perox-
ide. The reaction was stopped in 0.1 M
Tris and slides were dipped brieﬂy in water
and 70% ethanol.
After immunocytochemical detection of
digoxigenin-labeled cRNA probes, autoradio-
graphical detection of radiolabeled probes
was carried out by dipping the sections in
NTB3 emulsion (Eastman Kodak) diluted
1:1 with deionized, distilled water. Slides
were exposed for 4–6 weeks at 4°C and then
developed in Dektol and Kodak ﬁxer.
Data Analysis
The percentage of change in body weight
between GD 15 and GD 20 in TCDD-
treated and control dams was determined
and values were compared using Student’s t-
test. Body weights of both male and female
pups exposed to TCDD on GD 15 were
compared with those of unexposed pups
using two-way analysis of variance (ANOVA)
with sex and treatment as the main effects.
The effects of TCDD on GAD, PR, and
CYP1B1 gene expression in pups were evalu-
ated by determining relative corrected film
density of the autoradiographic signals on X-
ray ﬁlms as described previously (53,58). X-
ray films were placed on a light box and
images were obtained with a 3CCD Video
Camera (Hitachi Denshi America, Ltd.,
Woodbury, NY, USA) and an AF Micro-
Nikkor 60-mm objective lens (Nikon USA,
Melville, NY, USA). Images were digitized
using BioQuant Windows image analysis
software (R and M Biometrics, Nashville,
TN, USA), and a threshold was set to high-
light pixels representing speciﬁc labeling. The
region of interest was then circumscribed and
the average gray level of highlighted pixels
(ﬁlm density) was obtained for each region.
To control for possible differences in back-
ground signal among sections, we also
obtained density readings for adjacent back-
ground regions. To determine background
level, we set the threshold to highlight all pix-
els in the ﬁeld over a tissue region that had no
specific signal (areas containing only white
matter). This value was subtracted from the
value of the speciﬁc signal to obtain corrected
density readings. All sections were examined
using the same threshold settings so that rela-
tive treatment differences could be deter-
mined. Computer-assisted image analysis
compresses film autoradiographic responses
into a 255-level gray scale, of which only
60–80 gray levels fall in the range of film
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Figure 1. Photographs of X-ray ﬁlm autoradiograms resulting from hybridizing 12-µm liver sections to 33P-
labeled antisense (A,C) or sense (B,D) strand cRNA probes for CYP1B1 mRNA. Tissues were obtained
from PND-3 pups of dams treated with 1 µg TCDD/kg body weight (A,B) or vehicle (C,D) on GD 15.
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Figure 2. Effects of TCDD on CYP1B1 mRNA levels
in liver sections from PND-3 pups exposed to TCDD
(1 µg/kg po to dams; n = 5) or vehicle (n = 7) on GD
15. Bars represent mean (±SE) of autoradiographic
signals corrected for background differences.
****Significantly different from vehicle-treated
counterparts (p < 0.0001).Environmental Health Perspectives • VOLUME 110 | SUPPLEMENT 3 | JUNE 2002 373
density. Furthermore, X-ray ﬁlm responses to
radioactivity are logarithmic, not linear; there-
fore, a change in gray scale range of 20 corre-
sponds to as much as a 5-fold change in
radioactivity in the specimen [see Vizi et al.
(59) for discussion of this issue]. Thus, values
obtained using this method of analysis repre-
sent relative changes in gene expression, not
changes in absolute levels of mRNA, which
are substantially larger. However, ISHH
measurement of relative differences using ﬁlm
autoradiographical analysis provides the only
reliable method of detecting region-specific
changes in levels of gene expression.
For statistical analyses, we calculated the
mean corrected density of replicate sections
from individual animals in specific regions
(6–8 sections/region/animal) and obtained
from these a grand mean for each group and
each region. These data were analyzed using
two-way ANOVA, followed by Bonferroni’s
t-tests when we detected a signiﬁcant inter-
action between sex and treatment.
Results
We found no signiﬁcant treatment effects on
weights of dams at any time point and no sex
differences or treatment effects on body
weights of pups. We found that CYP1B1
gene expression in pup livers (see Figure 1 for
an example of autoradiographic signals) was
signiﬁcantly higher in TCDD-treated than in
control animals (Figure 2). We found no sig-
nificant differences in the expression of
CYP1B1 in pup livers between sexes. In con-
trast, PR mRNA levels (see Figure 3 for an
example of autoradiographic signals) were
significantly lower in females than in males
on PND 3. These differences were not
altered by TCDD exposure (Figure 4).
Results of dual-label ISHH studies
(Figure 5) demonstrated that all GABAergic
neurons detected in the POA contained AhR
mRNA, regardless of region. Despite the
uniform co-localization of GAD and AhR
mRNAs, effects of TCDD on GAD 67 gene
expression differed among regions and also
between sexes. Figure 6 shows examples of
autoradiographic ISHH signals for GAD 67
mRNA in the rPOA/AVPV region (Figure
6A), the rostral MPN (Figure 6B), and the
caudal MPN (Figure 6C). In the
rPOA/AVPV region, GAD 67 mRNA levels
were significantly higher in females than in
males; this difference was abolished by a
TCDD-induced decrease in levels detected
only in females (Figure 7A). Although GAD
67 mRNA levels in the rostral MPN region
were also signiﬁcantly higher in females than
in males, we saw no effects of TCDD
(Figure 7B). Finally, in the caudal MPN
(Figure 7C), we found no sex differences in
GAD 67 mRNA levels in vehicle-treated
pups. However, in this region TCDD
decreased levels speciﬁcally in males.
Discussion
The results of these studies show that
although virtually all GABAergic neurons in
the developing POA contained AhR mRNA,
TCDD altered GAD 67 gene expression in a
region-speciﬁc manner that differed between
sexes. These effects do not appear to be sec-
ondary to suppression of testosterone levels,
because androgen-dependent sex differences
in PR gene expression in the MPN were not
altered by TCDD. Furthermore, considering
that TCDD decreased GAD 67 levels in
both males and females, and that effects var-
ied among regions, these changes are proba-
bly not attributable solely either to
antiestrogenic effects of TCDD or to AhR
activation of xenobiotic response elements in
the promoter region of the GAD 67 gene.
These findings suggest that AhR activation
in the brain may affect multiple signaling
pathways, some of which are sex- and
region-specific. Although the mechanisms
responsible for disruption of GAD 67 gene
expression remain to be determined, our
results clearly show that GABAergic neurons
in POA regions important for gonadotropin
release and male sexual behavior are targets
of TCDD during development.
The present findings are the first to
show that females have higher levels of
GAD 67 mRNA levels than males in both
the rPOA/AVPV and the caudal MPN
regions but not in the more rostral MPN
region. These regional differences may have
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Figure 5. (A) Low-magniﬁcation (10× objective) photomicrograph showing emulsion autoradiogram result-
ing from hybridization of MPN tissue sections to digoxigenin-labeled cRNA probes for GAD mRNA (GAD
65 and GAD 67; brown stain over cytoplasm) and 33P-labeled probes for AhR mRNA (black silver grains).
3V, third ventricle. (B) Higher magniﬁcation (40× objective) of same section shown in (A).
Figure 4. Sexual differences in PR mRNA levels in
caudal MPN region of untreated PND-3 pups. Bars
represent mean (±SE) of autoradiographic signals
corrected for background. ****Signiﬁcantly differ-
ent from male counterparts (p < 0.0001).
Figure 3. Representative film autoradiogram
resulting from hybridization of MPN brain sec-
tions of untreated male (A) and female (B) PND-3
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important physiological implications and
emphasize the importance of considering
subdivisions of the POA as functionally dis-
tinct groups of neurons. Previous work did
not detect consistent sex differences in GAD
67 gene expression in the POA of Sprague-
Dawley rats on either PND 1 or 15 using
ISHH or ribonuclease protection assays
(60). In their ISHH studies, these
researchers did not examine the rPOA/
AVPV region and only compared single sec-
tions at the level of the sexually dimorphic
nucleus of the POA, a region in which oth-
ers also failed to detect sex differences in
GAD 67 gene expression (61). Furthermore,
in the ribonuclease protection assays, they
used tissue punches of the mPOA that
included regions we analyzed separately in
the present study (subdivisions we termed
rostral and caudal MPN). It seems likely
that pooling tissues could mask the region-
speciﬁc sex differences we detected in GAD
67 mRNA levels in the caudal MPN
region. Thus, methodological differences
likely explain apparent discrepancies
between results; nevertheless, differences in
rat strain or the age at which pups were
examined could also contribute to these
divergent results.
GAD 67 gene expression in the rPOA/
AVPV was higher in untreated females than
in male counterparts because the AVPV
plays a key role in the elicitation of LH-
releasing hormone and LH surge release by
ovarian steroids in females. For example,
microimplants of antiestrogen block the
surge in E2-treated ovariectomized animals
(33,34). Likewise, lesions of this region
block the ability of progesterone to elicit LH
surge release in estrogen-treated rats (62).
Finally, specifically in the rPOA/AVPV, E2
elicits temporal changes in GAD 67 mRNA
levels that mark events required for the
induction of LH surge release (44). Further
studies are required to determine the
mechanisms responsible for the observed sex
differences and to determine whether differ-
ences in GABAergic activity during develop-
ment are responsible for the sexually
dimorphic structural features and functions
of the AVPV in adulthood.
We found that TCDD exposure abolished
sex differences in GAD 67 gene expression in
the rPOA/AVPV by specifically decreasing
expression in females. Previous work shows
that female rats exposed to this dose of
TCDD during development show delayed
onset of puberty and increased time required
to achieve pregnancy in a continuous mating
situation (17,18). In concert with the pres-
ent findings, GABAergic neurons in the
POA have been implicated previously in the
onset of puberty. Together with the com-
pelling evidence that GABAergic neurons of
the AVPV play a role in E2-dependent LH
surge release and ovulation, it is reasonable
to speculate that the underlying cause of dis-
ruptions in female reproductive functions is
a TCDD-induced suppression of GABA
synthesis during development. Nonetheless,
TCDD exposure did not affect rPOA/
AVPV levels of GAD 67 mRNA in males,
despite previous evidence that exposure to a
maternal dose of 1 µg/kg TCDD on GD 15
feminizes gonadotropin release patterns in
Holtzman male rats (13).
Although we found no sex differences in
GAD 67 gene expression in the caudal MPN,
TCDD decreased expression in this region
speciﬁcally in males. This ﬁnding is intrigu-
ing in view of previous work showing that
the caudal MPN is important for the expres-
sion of male sexual behaviors (35,36) that are
altered by developmental exposure to TCDD
(13). Unlike other regions of the POA, the
caudal MPN of males has approximately 5
times as many androgen receptors as does
that of females (45) and therefore may be the
primary target for androgen action during
sexual differentiation of the substrates impor-
tant for masculine behaviors in adulthood.
Whether TCDD-induced reduction in the
activity of GABAergic neurons in the caudal
MPN could interfere with behavioral mas-
culinization is not clear, especially consider-
ing that we found no sex differences in GAD
67 gene expression in untreated animals.
However, previous work shows that perinatal
treatment with the GABAA receptor antago-
nist picrotoxin permanently decreases male
sexual behavior in adulthood (63). In light of
this information and our ﬁnding that nearly
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Figure 7. Effects of developmental exposure to
TCDD (1 µg/kg po to dams on GD 15; n = 5) or vehi-
cle (n = 7) on GAD 67 mRNA levels in male and
female rats examined on PND 3. Bars represent
mean (±SE) autoradiographic signals corrected
for background differences. *Significantly differ-
ent between sexes (p < 0.05). **Significantly dif-
ferent between sexes (p < 0.005). +Significantly
different from vehicle-treated counterpart of
same sex (p < 0.05). 
Figure 6. Photographs of autoradiograms result-
ing from hybridization of tissue sections from the
(A) rPOA/AVPV region, (B) the rostral MPN, and
(C) the caudal MPN to 35S-labeled cRNA probes
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all AhR mRNA signal is accounted for by
co-localization with GAD mRNA, TCDD-
induced decreases in GAD 67 gene expres-
sion in the caudal MPN of males could have
permanent consequences, including deficits
in masculine sexual behaviors.
The mechanisms underlying the variable
effects of TCDD on GAD 67 gene expres-
sion in males and females will require fur-
ther research, but our present findings
provide important new insights. First, we
found that sex differences in PR mRNA
levels in the MPN were not affected by
TCDD administration. Because this sex
difference depends on androgen action
(46,47), presumably through aromatization
to E2, it seems unlikely that TCDD dis-
rupted GAD 67 gene expression by inter-
fering with testosterone production in
males. Second, we found that TCDD
decreased GAD 67 mRNA levels, but it did
so in both males (caudal MPN region) and
females (AVPV region). Thus, effects of
TCDD are probably not attributable to
interference with estrogen action in the
developing brain, because only males are
exposed to relatively high levels of E2
through local aromatization of circulating
androgens. Finally, TCDD did not have
the same effect on GAD 67 gene expression
in all regions, even though we found no
regional differences in the percentage of co-
localization of GAD and AhR mRNAs.
This ﬁnding suggests that effects of TCDD
do not result solely from a genomic action
of the AhR on GAD 67 gene expression.
On the basis of this evidence, it seems likely
that TCDD effects on GAD 67 gene
expression may involve a complex interac-
tion among genomic effects of AhR activa-
tion, disruption of sex-specific genomic
effects of steroids, and alterations in region-
speciﬁc signal transduction pathways.
In summary, we found that GABAergic
neurons in the POA express the AhR gene
and that TCDD exposure during develop-
ment alters GAD 67 gene expression in a
region- and sex-speciﬁc manner. Of particu-
lar importance is the finding of disruptive
effects of TCDD in the rPOA/AVPV and
caudal MPN. These regions play a key role
in female fertility and regulation of male sex-
ual behaviors, functions that previous work
found to be disrupted when developing ani-
mals are exposed to the same dose of TCDD
and the same time of administration used in
the present studies. Although the mechan-
isms underlying TCDD disruptions of GAD
67 gene expression are not readily apparent,
they are likely to involve complex interac-
tions of genomic and nongenomic AhR and
ER pathways in GABA neurons, as well as
modulation of region-speciﬁc afferent signals
to GABAergic neurons.
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